Back in 2010, Beverly Mitchell, MD, director of the Stanford Cancer Institute and a professor of medicine, gave us an overview of the landscape of cancer research and treatment. Since that time, significant strides have been made - from the use of genomic analysis, molecular biology, imaging technologies and data management - and these advances have made cancer treatment less toxic and more tailored to the individual patient.
In his latest 1:2:1 podcast, Paul Costello, the medical school's chief communications officer, talks with Mitchell about these advancements and new Stanford initiatives to transform care.
Previously: The big C
